Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Aug 1;13(4):703-705.
doi: 10.21037/hbsn-24-294. Epub 2024 Jul 18.

Minimally invasive liver resection in metabolic syndrome: insights and future directions

Kechun Wang #  1 , Yifan Li #  2 , Jinbo Gong #  2 , Mingda Wang  1 , Tian Yang  1
Affiliations
Editorial

Minimally invasive liver resection in metabolic syndrome: insights and future directions

Kechun Wang et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Minimally invasive surgery; hepatectomy; metabolic syndrome (MS); survival.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-294/coif). T.Y. serves as an unpaid editorial board member of HepatoBiliary Surgery and Nutrition. The other authors have no conflicts of interest to declare.

Comment on

  • Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome.
    Berardi G, Ivanics T, Sapisochin G, Ratti F, Sposito C, Nebbia M, D'Souza DM, Pascual F, Tohme S, D'Amico FE, Alessandris R, Panetta V, Simonelli I, Del Basso C, Russolillo N, Fiorentini G, Serenari M, Rotellar F, Zimitti G, Famularo S, Hoffman D, Onkendi E, Lopez-Ben S, Caula C, Rompianesi G, Chopra A, Abu Hilal M, Torzilli G, Corvera C, Alseidi A, Helton S, Troisi RI, Simo K, Conrad C, Cescon M, Cleary S, Kwon CHD, Ferrero A, Ettorre GM, Cillo U, Geller D, Cherqui D, Serrano PE, Ferrone C, Mazzaferro V, Aldrighetti L, Kingham TP. Berardi G, et al. Ann Surg. 2023 Nov 1;278(5):e1041-e1047. doi: 10.1097/SLA.0000000000005861. Epub 2023 Mar 30. Ann Surg. 2023. PMID: 36994755 Free PMC article.

References

    1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229-63. 10.3322/caac.21834 - DOI - PubMed
    1. Llovet JM, Willoughby CE, Singal AG, et al. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol 2023;20:487-503. 10.1038/s41575-023-00754-7 - DOI - PMC - PubMed
    1. Wang MD, Diao YK, Yao LQ, et al. Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma. iLIVER 2024;3:100083.
    1. Wang MD, Tang SC, Li C, et al. Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection: A Multicenter Study of 1753 Patients. Ann Surg Oncol 2023;30:346-58. 10.1245/s10434-022-12529-6 - DOI - PubMed
    1. Wang MD, Shen F, Zeng YY, et al. ASO Author Reflections: Effect of Preoperative Metabolic Syndrome for Patients with Hepatocellular Carcinoma. Ann Surg Oncol 2023;30:359-60. 10.1245/s10434-022-12557-2 - DOI - PubMed